目的 对于尿毒症继发甲状旁腺功能亢进患者接受手术治疗的麻醉管理进行探讨。方法 选取2018年1月—2020年1月接诊的尿毒症继发甲状旁腺功能亢进患者20例为观察对象,所选20例尿毒症继发甲状旁腺功能亢进患者全部接受全麻下甲状旁腺切除手术治疗,通过回顾性分析方法分析患者的麻醉管理情况。结果 20例尿毒症继发甲状旁腺功能亢进患者在全麻状态下完成手术治疗,其中14例患者手术期间产生低血压,10例患者手术期间接受去甲肾上腺素持续泵注,患者手术之后的血钙以及血磷水平和手术之前1 d对比不存在明显差异,手术之后1 d的钙离子浓度显著低于手术之前1 d。手术之后8例患者产生低钙表现,其中5例低钙血症患者在手术之后第1天产生口唇麻木以及手指麻木感,通过及时的补钙治疗麻木症状消失。2例患者手术期间产生高钾血症,通过极化液之后血钾水平恢复到正常。20例尿毒症继发甲状旁腺功能亢进患者的苏醒时间平均为(8.50±1.16)min,拔管时间平均为(9.24±1.59) min。20例患者麻醉效果:Ⅰ级10例,Ⅱ级8例,Ⅲ级2例,麻醉有效率为90.0%。结论 尿毒症继发甲状旁腺功能亢进患者接受全麻诱导之后和手术期间十分容易产生低血压表现,手术期间需要严格监测患者的血压水平,合理选择升压药物,并且提高电解质的监测力度,从而提高手术麻醉安全性。
Objective To discuss the anesthesia management in surgical treatment of uremia secondary hyperparathyroidism. Methods Twenty patients with uremia secondary hyperparathyroidism who were admitted from January 2018 to January 2020 were selected as study subjects, and treated by parathyroidectomy under general anesthesia. Their anesthesia management was analyzed retrospectively. Results During the surgery, 14 out of the 20 patients had low blood pressure, and 10 patients received continuous pumping of norepinephrine. The blood calcium and blood phosphorus levels after surgery were not significantly different from those 1 day before surgery. The calcium ion concentration 1 day after surgery was significantly lower than that 1 day before surgery. Among the 8 patients who developed hypocalcemia after surgery, 5 patients developed numbness in the lips and fingers 1 day after surgery, and then received timely calcium supplementation to address the symptoms. Hyperkalemia occurred in 2 patients during operation, and their serum potassium level were reduced to a normal range after glucose-insulin-potassium solution. The average waking time and extubation time of the 20 patients with uremia secondary hyperparathyroidism were (8.50±1.16) min and (9.24±1.59) min respectively. The distributions of the anesthesia effects among the 20 patients were level I for 10 cases, level Ⅱ for 8 cases, and level Ⅲ for 2 cases; the effective rate of anesthesia was 90.0%. Conclusion Patients with hyperparathyroidism secondary to uremia are very likely to have hypotension after induction of general anesthesia and during the operation. The patients’ blood pressure and electrolyte should be strictly monitored during the operation, and hypertensors should be applied as appropriate, thus ensuring the safety of surgical anesthesia.
[1] 邓荣芳,王利民,唐美艳.甲状旁腺全部切除加自体移植术治疗尿毒症维持性透析患者继发性甲状旁腺功能亢进症的临床疗效分析[J].中国社区医师,2020,36(13):81-82.
[2] 蔡常青,李洪春,王利民,等.甲状旁腺全切除+自体移植术治疗继发甲状旁腺功能亢进的疗效观察[J].医学理论与实践,2020,33(7):1111-1112.
[3] 杨娜,杨永林,王燕,等.高通量透析器用于尿毒症继发甲状旁腺功能亢进患者对钙磷代谢状态和预后的影响[J].中国医学装备,2020,17(3):108-112.
[4] 胡菂菂,李恩就,王兴.甲状旁腺全切除加前臂自体移植术对继发性甲状旁腺功能亢进症患者心脏功能的影响[J].广州医药,2020,51(1):113-116.
[5] 崔恒官,沈卫星,吴伟新,等.尿毒症继发性甲状旁腺功能亢进患者甲状旁腺全切+前臂自体移植术后的疗效观察[J].哈尔滨医科大学学报,2019,53(6):657-659+666.
[6] 姜爱芹. 尿毒症患者血液透析并发继发性甲状旁腺功能亢进的临床表现与治疗预后研究[J].中国实用医药,2019,14(33):55-57.
[7] 王杨,胡凤琪,吴慧杰.维持性血液透析并发继发性甲状旁腺功能亢进患者血Treg、Th17、iPTH、ALP表达特点分析[J].中国医学前沿杂志(电子版),2019,11(10):110-113.
[8] 金哲,廖爱能,吴文胜,等.血液透析滤过联合血液灌流治疗尿毒症继发甲状旁腺功能亢进的临床效果[J].中国当代医药,2019,26(28):90-93.
[9] 吴勐,邱泱,丘昭文,等.甲状旁腺切除术对尿毒症继发甲状旁腺功能亢进症的维持性血液透析患者肾性贫血的影响[J].中国实用内科杂志,2019,39(10):900-903.
[10] 鹿冬梅,杨沿浪,王金宝,等.西那卡塞联合骨化三醇对MHD尿毒症继发甲状旁腺功能亢进患者矿物质及骨代谢的影响[J].贵州医科大学学报,2019,44(8):965-970.
[11] 庄逸淳. 不同治疗方式对改善尿毒症继发甲状旁腺功能亢进症维持性血液透析患者肾性贫血的影响[J].世界最新医学信息文摘,2019,19(74):92-93.
[12] 王绍勇,谭忠麒,袁锋.甲状旁腺全切除术联合自体移植术治疗尿毒症所致继发性甲状旁腺功能亢进症的效果[J].当代医药论丛,2019,17(9):117-119.